Understanding Psychedelic-Assisted Therapy Research for Depression
Depression is one of the most studied conditions in psychiatry, yet a large number of people don't respond fully to standard antidepressants. In recent years, researchers have turned renewed attention to a class of investigational treatments with a very different profile: psychedelic compounds, studied under strict clinical protocols for their potential to treat depression symptoms.
Why Researchers Are Studying Psychedelics for Depression
Traditional antidepressants (SSRIs, SNRIs, and others) are taken daily and often take weeks to build up an effect. Psychedelic-assisted research explores a different model — a single, carefully administered dose, given in a controlled clinical setting, paired with close monitoring by the study team.
This isn't about self-directed or recreational use. Every aspect of a clinical trial involving these compounds — dosing, setting, medical supervision, and follow-up — is defined by a strict protocol reviewed and approved by an Institutional Review Board (IRB) before a single participant is enrolled. Safety monitoring is built into every stage.
One example is a study currently enrolling at Inner Space Research, evaluating a single 100 microgram dose of MM-120 (a form of LSD studied in a clinical research context) against placebo, specifically for its effect on depression symptoms.
What Makes This Kind of Trial Different
Compared to a typical medication trial, psychedelic-assisted studies usually involve more hands-on structure around the dosing day itself:
A controlled clinical environment for the dosing session, with trained staff present throughout. Extended monitoring on the day of dosing, since effects can last several hours. Follow-up visits afterward to track how symptoms evolve over the following days and weeks.
This is a meaningfully different experience than picking up a prescription and taking it at home, and it's part of why these studies require a more involved screening process.
Who Might Qualify
Depression studies involving investigational compounds like MM-120 typically look for adults who:
Have a diagnosis of depression and are currently experiencing symptoms. Are medically stable enough to safely undergo the study procedures. Don't have specific medical or psychiatric histories that the protocol excludes (this varies by study and is assessed individually).
As with any trial, eligibility can only be confirmed through a proper screening process — no online quiz or self-assessment can replace that.
What Screening and Participation Involve
If you're interested, the process generally starts with a conversation with the study team about your history and current symptoms. If you appear to be a good fit, you'll come in for a more complete evaluation, which may include a psychiatric assessment, physical exam, and lab work.
Once enrolled, you'll follow the schedule set out by the study protocol — including the dosing visit itself and follow-up appointments where the team tracks your symptoms using standardized rating scales. Depending on the trial design, you may receive the investigational treatment or a placebo, which is how researchers determine whether the treatment itself is responsible for any changes observed.
What Participants Gain
Beyond the possibility of symptom improvement, participants typically receive study-related care at no cost and a level of clinical attention and follow-up that goes beyond routine outpatient care. You're also contributing to research that could shape how depression is treated for people who haven't found relief through conventional options.
Is This the Right Fit for You?
If you're an adult in the Orem, Utah area living with depression and interested in learning more about investigational treatment research, our current study evaluating MM-120 may be worth exploring. Reaching out starts with a conversation — no obligation, just information.
Learn more about our current depression study →
This article is for general educational purposes and is not a substitute for medical advice. Please consult your healthcare provider about your specific situation and treatment options.